DIN 02552981 — OJJAARA 200 MG
OJJAARA is a tablet of Momelotinib marketed by GLAXOSMITHKLINE INC. The full Momelotinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02552981
- Brand name
- OJJAARA
- Active ingredient
- Momelotinib
- Strength
- 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Janus kinase (JAK1/JAK2) inhibitor (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Momelotinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02552965 | OJJAARA | 100 MG | TABLET | GLAXOSMITHKLINE INC | MARKETED |
| 02552973 | OJJAARA | 150 MG | TABLET | GLAXOSMITHKLINE INC | MARKETED |